This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rochester Medical Corp CEO Discusses Q1 2011 Results - Earnings Call Transcript

Rochester Medical Corp ( ROCM)

Q1 2011 Earnings Call

January 25, 2011 4:30 p.m. ET


Anthony Conway - CEO

David Jonas - Chief Financial Officer


Tyson Bauer - Wealth Monitors

Ernie Andberg - Feltl & Company

Larry Haimovitch - HMTC

Beth Lilly - Gabelli Investors

William Hanson - individual investor



Great day ladies and gentlemen and welcome to the first quarter 2011 Rochester Medical Corporation earnings conference call. My name is Thelma and I will be your coordinator for today’s event. At this time all participants are in a listen only mode. We will facilitate a question and answer session towards the end of this presentation. You may press star, 1 on your touchtone telephone at any time to pose a question.

If at any time during this call you require assistance please key star followed by 0 and a coordinator will be happy to assist you. As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to Mr. Anthony J. Conway, President and CEO. Please go ahead.

Anthony Conway

Thank you for joining Rochester Medical’s first quarter conference call. I’m Jim Conway, the company’s President and CEO and with me is David Jonas, Rochester Medical’s Chief Financial Officer. To start I will review the highlights of the quarter and then David will present additional information on the financials and more detail on the pending acquisition. After that we will give you some further insight into our plans for the future and then take questions.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs